| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/03/2008 | WO2007081447A3 Norovirus and sapovirus antigens |
| 04/03/2008 | WO2006083971A3 Dr5 antibodies and uses thereof |
| 04/03/2008 | US20080081794 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 04/03/2008 | US20080081050 Vaccine against streptococcus pneumoniae |
| 04/03/2008 | US20080081049 Treatment of fine wrinkles with clostridia neurotoxins |
| 04/03/2008 | US20080081048 Production of modified neurotoxins |
| 04/03/2008 | US20080081047 severe acute respiratory syndrome; preparing a chimeric antibody; Monoclonal antibody reagents that recognize the SARS-coronavirus (SARS-HCoV) |
| 04/03/2008 | US20080081045 Combination Therapy for Cancer |
| 04/03/2008 | US20080081044 Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes |
| 04/03/2008 | US20080081043 Nucleotide sequences coding natural killer cell ligand for use as tool in treatment cell proliferative disorders |
| 04/03/2008 | US20080081042 Passive Immunization and methods of treament for anthrax using antibodies |
| 04/03/2008 | US20080081041 Method of Using IL6 Antagonists with Mitoxantrone for Prostate Cancer |
| 04/03/2008 | US20080081040 Using monclonal antibody for treatment and prevention of discomfort associated with cell proliferative disorders |
| 04/03/2008 | US20080081039 Inorganic Selenium For Treatment Of Cancer |
| 04/03/2008 | US20080081038 Immunoglobulin fusion for prevention and treatment of cell proliferative disorders |
| 04/03/2008 | US20080081037 Methods and Agents for Diagnosis and Prevention, Amelioration or Treatment of Goblet Cell-Related Disorders |
| 04/03/2008 | DE102007016151A1 Beschichtetes Implantat Coated implant |
| 04/03/2008 | CA2700579A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2700436A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2700218A1 Live bacterial vaccines for viral infection prophylaxis or treatment |
| 04/03/2008 | CA2664795A1 Therapeutic compositions to improve the effect of the therapy with anti-epidermal growth factor receptor antibodies |
| 04/03/2008 | CA2664763A1 Prostaglandin e2 (pge2) as an adjuvant in monoclonal antibody generation |
| 04/03/2008 | CA2664752A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | CA2664740A1 Combination treatment of cd38-expressing tumors |
| 04/03/2008 | CA2664418A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases |
| 04/03/2008 | CA2664359A1 Cytokine signaling |
| 04/03/2008 | CA2663892A1 Stabilized antibody formulations and uses thereof |
| 04/03/2008 | CA2663851A1 Compositions and methods for enhancing an adjuvant |
| 04/03/2008 | CA2663243A1 Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use |
| 04/03/2008 | CA2658559A1 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions |
| 04/02/2008 | EP1906184A1 Diagnostic agent and therapeutic agent for disease related to macrocyte and macrophage |
| 04/02/2008 | EP1905844A2 Application of mRNA for use as a therapeutic agent against tumours |
| 04/02/2008 | EP1905834A2 Virulence Genes, Proteins, and their Use |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905831A2 Lactoferrin receptor genes of moraxella |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905780A1 Cancer suppressing agent |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1905304A2 Treatment of neoplasms with viruses |
| 04/02/2008 | EP1904850A2 Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus |
| 04/02/2008 | EP1904630A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene |
| 04/02/2008 | EP1904626A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 04/02/2008 | EP1904531A2 Novel madcam antibodies |
| 04/02/2008 | EP1904530A2 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 04/02/2008 | EP1904524A2 Variant iaspp polypeptide and screening assay |
| 04/02/2008 | EP1904520A2 A vaccine for staphylococcal infections |
| 04/02/2008 | EP1904106A2 Reagents for the detection of phosphorylated atr kinase (ser 428/ser 2317) and uses thereof |
| 04/02/2008 | EP1904105A2 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/02/2008 | EP1904104A2 Sp35 antibodies and uses thereof |
| 04/02/2008 | EP1904103A2 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 04/02/2008 | EP1904102A1 Anti-ccr7 receptor antibodies for the treatment of cancer |
| 04/02/2008 | EP1904101A2 Anti-cd19 antibody therapy for the transplantation |
| 04/02/2008 | EP1904100A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
| 04/02/2008 | EP1904099A2 Thermoreversible immuno- adjuvant emulsion |
| 04/02/2008 | EP1904098A2 A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine |
| 04/02/2008 | EP1904097A2 Malaria msp-1 c-terminal enhanced subunit vaccine |
| 04/02/2008 | EP1904096A2 Mycoplasma subunit vaccine |
| 04/02/2008 | EP1904095A1 Treatment of liver cirrhosis and its complications |
| 04/02/2008 | EP1904081A2 Compositions and methods to control angiogenesis with cupredoxins |
| 04/02/2008 | EP1904080A1 Lkktet and/or lkktnt compositions and methods for treating or preventing tissue deterioration, injury or damage |
| 04/02/2008 | EP1327680B1 Modified tpo agonist antibody |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | EP0822985B1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| 04/02/2008 | EP0822830B1 Human anti-IL-8 antibodies, derived from immunized xenomice |
| 04/02/2008 | EP0789587B2 Combined meningitis vaccine |
| 04/02/2008 | EP0725653B2 Vaccine compositions |
| 04/02/2008 | EP0666911B1 Multidrug resistance gene |
| 04/02/2008 | CN101155919A Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof |
| 04/02/2008 | CN101155833A Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation |
| 04/02/2008 | CN101155831A Anti-interferon alpha monoclonal antibodies and methods for use |
| 04/02/2008 | CN101155830A Antibodies that bind to epha2 and methods of use thereof |
| 04/02/2008 | CN101155601A Bioactive stents for type ii diabetics and methods for use thereof |
| 04/02/2008 | CN101155597A Nucleic acid constructs |
| 04/02/2008 | CN101155596A Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
| 04/02/2008 | CN101153284A Gene of sheep type brucella M5 mycopremna ribosomal protein L7, its encoding protein and application |
| 04/02/2008 | CN101153280A Method for purifying human papilloma virus advanced protein from prokaryote |
| 04/02/2008 | CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152572A Preparations of monoclone antibody |
| 04/02/2008 | CN101152571A Vaccine wine oil adjuvant containing momordica cochinchinensis soap and method for preparing the same |
| 04/02/2008 | CN101152570A Epitope vaccine of hog cholera virus and its preparing process |
| 04/02/2008 | CN100378223C Pylorus screw bacterium fenestra element having adhesion function |
| 04/02/2008 | CN100378216C 9M-negative EHV-mutants |
| 04/02/2008 | CN100378127C Antibodies against insulin-like growth factor I receptor and application thereof |
| 04/02/2008 | CN100378124C Hsp70 from arthrobacter |
| 04/02/2008 | CN100378123C Chimeric chains that code for proteins that induce effects directed against viruses |
| 04/02/2008 | CN100378121C Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 04/02/2008 | CN100378118C Pharmaceutical compositions having appetite suppressant activity |
| 04/01/2008 | US7351855 Chemically defined non-polymeric valency platform molecules and conjugates thereof |
| 04/01/2008 | US7351804 Antibodies against PRO4421 |
| 04/01/2008 | US7351803 CD16A binding proteins and use for the treatment of immune disorders |
| 04/01/2008 | US7351797 Labeled peptides, and processes and intermediates useful for their preparation |
| 04/01/2008 | US7351795 PRO19563 polypeptides |
| 04/01/2008 | US7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers |
| 04/01/2008 | US7351693 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 04/01/2008 | US7351686 Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides |
| 04/01/2008 | US7351583 Antibodies to G protein-coupled receptor |
| 04/01/2008 | US7351570 Hepatitis d viral nucleotide sequences for use in diagnosis of hepatitis b infection |
| 04/01/2008 | US7351566 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |